186 related articles for article (PubMed ID: 24601643)
1. Histone H1 phosphorylation in breast cancer.
Harshman SW; Hoover ME; Huang C; Branson OE; Chaney SB; Cheney CM; Rosol TJ; Shapiro CL; Wysocki VH; Huebner K; Freitas MA
J Proteome Res; 2014 May; 13(5):2453-67. PubMed ID: 24601643
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Mass Spectrometry Reveals that Intact Histone H1 Phosphorylations are Variant Specific and Exhibit Single Molecule Hierarchical Dependence.
Chen Y; Hoover ME; Dang X; Shomo AA; Guan X; Marshall AG; Freitas MA; Young NL
Mol Cell Proteomics; 2016 Mar; 15(3):818-33. PubMed ID: 26209608
[TBL] [Abstract][Full Text] [Related]
3. Global changes in and characterization of specific sites of phosphorylation in mouse and human histone H1 Isoforms upon CDK inhibitor treatment using mass spectrometry.
Deterding LJ; Bunger MK; Banks GC; Tomer KB; Archer TK
J Proteome Res; 2008 Jun; 7(6):2368-79. PubMed ID: 18416567
[TBL] [Abstract][Full Text] [Related]
4. Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer.
Gonzalez ME; DuPrie ML; Krueger H; Merajver SD; Ventura AC; Toy KA; Kleer CG
Cancer Res; 2011 Mar; 71(6):2360-70. PubMed ID: 21406404
[TBL] [Abstract][Full Text] [Related]
5. AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells.
Rabi T; Huwiler A; Zangemeister-Wittke U
Mol Carcinog; 2014 Jul; 53(7):578-88. PubMed ID: 23475563
[TBL] [Abstract][Full Text] [Related]
6. Insulin-stimulated cell growth in insulin receptor substrate-1-deficient ZR-75-1 cells is mediated by a phosphatidylinositol-3-kinase-independent pathway.
Gliozzo B; Sung CK; Scalia P; Papa V; Frasca F; Sciacca L; Giorgino F; Milazzo G; Goldfine ID; Vigneri R; Pezzino V
J Cell Biochem; 1998 Aug; 70(2):268-80. PubMed ID: 9671232
[TBL] [Abstract][Full Text] [Related]
7. Isolation and analysis of linker histones across cellular compartments.
Harshman SW; Chen MM; Branson OE; Jacob NK; Johnson AJ; Byrd JC; Freitas MA
J Proteomics; 2013 Oct; 91():595-604. PubMed ID: 24013129
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1.
Li J; Yang L; Song L; Xiong H; Wang L; Yan X; Yuan J; Wu J; Li M
Oncogene; 2009 Sep; 28(36):3188-96. PubMed ID: 19633686
[TBL] [Abstract][Full Text] [Related]
9. Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways.
Yue W; Wang JP; Conaway MR; Li Y; Santen RJ
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):265-74. PubMed ID: 14623520
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
[TBL] [Abstract][Full Text] [Related]
11. Runx2 activates PI3K/Akt signaling via mTORC2 regulation in invasive breast cancer cells.
Tandon M; Chen Z; Pratap J
Breast Cancer Res; 2014 Jan; 16(1):R16. PubMed ID: 24479521
[TBL] [Abstract][Full Text] [Related]
12. Estradiol rapidly activates Akt via the ErbB2 signaling pathway.
Stoica GE; Franke TF; Wellstein A; Czubayko F; List HJ; Reiter R; Morgan E; Martin MB; Stoica A
Mol Endocrinol; 2003 May; 17(5):818-30. PubMed ID: 12554767
[TBL] [Abstract][Full Text] [Related]
13. Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.
Ghayad SE; Vendrell JA; Ben Larbi S; Dumontet C; Bieche I; Cohen PA
Int J Cancer; 2010 Jan; 126(2):545-62. PubMed ID: 19609946
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
Ripple MO; Kalmadi S; Eastman A
Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
[TBL] [Abstract][Full Text] [Related]
15. t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer.
Vangamudi B; Peng DF; Cai Q; El-Rifai W; Zheng W; Belkhiri A
Mol Cancer; 2010 Sep; 9():240. PubMed ID: 20836878
[TBL] [Abstract][Full Text] [Related]
16. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.
Squires MS; Hudson EA; Howells L; Sale S; Houghton CE; Jones JL; Fox LH; Dickens M; Prigent SA; Manson MM
Biochem Pharmacol; 2003 Feb; 65(3):361-76. PubMed ID: 12527329
[TBL] [Abstract][Full Text] [Related]
17. Characterization of phosphorylation sites on histone H1 isoforms by tandem mass spectrometry.
Garcia BA; Busby SA; Barber CM; Shabanowitz J; Allis CD; Hunt DF
J Proteome Res; 2004; 3(6):1219-27. PubMed ID: 15595731
[TBL] [Abstract][Full Text] [Related]
18. [The relationship of mTOR signaling pathway and histone acetylation in human gastric cancer cell lines].
Sun DF; Fang JY; Zhang YJ; Tian XQ; Zhu HY; Li EL; Gu WQ; Shen GF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):387-91. PubMed ID: 17680526
[TBL] [Abstract][Full Text] [Related]
19. Estradiol-Induced MMP-9 Expression via PELP1-Mediated Membrane-Initiated Signaling in ERα-Positive Breast Cancer Cells.
Pan Y; Wang X; Zhang Y; Qiao J; Sasano H; McNamara K; Zhao B; Zhang D; Fan Y; Liu L; Jia X; Liu M; Song S; Wang L
Horm Cancer; 2020 Apr; 11(2):87-96. PubMed ID: 32037484
[TBL] [Abstract][Full Text] [Related]
20. Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo.
Zhang H; Chen D; Ringler J; Chen W; Cui QC; Ethier SP; Dou QP; Wu G
Cancer Res; 2010 May; 70(10):3996-4004. PubMed ID: 20424113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
